Author:
Tang Sicheng,Wang Wenchao,Wang Yijian,Gao Yuhan,Dai Keke,Zhang Wenjing,Wu Xudong,Yuan Xiaodie,Jin Chaofan,Zan Xingjie,Zhu Limeng,Geng Wujun
Funder
University of Chinese Academy of Sciences, Wenzhou Institute
Science and Technology Plan Project of Wenzhou Municipality
Zhejiang Provincial Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference72 articles.
1. Ouyang J, Zhang Z, Deng B, Liu J, Wang L, Liu H, Koo S, Chen S, Li Y, Yaremenko AV, et al. Oral drug delivery platforms for biomedical applications. Materials Today; 2023.
2. Baryakova TH, Pogostin BH, Langer R, McHugh KJ. Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems. Nat Rev Drug Disc. 2023;22(5):387–409.
3. Wu B, Kulkarni K, Basu S, Zhang S, Hu M. First-pass metabolism via udp-glucuronosyltransferase: a barrier to oral bioavailability of phenolics. J Pharm Sci. 2011;100(9):3655–81.
4. Date AA, Hanes J, Ensign LM. Nanoparticles for oral delivery: design, evaluation and state-of-the-art. J Control Release. 2016;240:504–26.
5. Deng B, Liu S, Wang Y, Ali B, Kong N, Xie T, Koo S, Ouyang J, Tao W. Oral nanomedicine: challenges and opportunities. Adv Mater. 2023;1:2306081.